BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

9213 related articles for article (PubMed ID: 11002192)

  • 1. Antitumor activity of alpha-fetoprotein conjugate with doxorubicin in vitro and in vivo.
    Feldman NB; Kiselev SM; Gukasova NV; Posypanova GA; Lutsenko SV; Severin SE
    Biochemistry (Mosc); 2000 Aug; 65(8):967-71. PubMed ID: 11002192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
    Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR
    Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic and antitumor activities of doxorubicin conjugates with the epidermal growth factor and its receptor-binding fragment.
    Lutsenko SV; Feldman NB; Severin SE
    J Drug Target; 2002 Nov; 10(7):567-71. PubMed ID: 12683724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Importance of the conjugated antibody for the induction of selective effect of adriamycin conjugated with anti AFP monoclonal antibody and entrapped in liposomes against AFP producing tumors].
    Konno H; Kumai K; Tsubouchi T; Ishibiki K; Abe O; Tadakuma T; Yasuda T; Nagaike K; Hosokawa S; Sakaguchi S
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2213-7. PubMed ID: 2472119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of alpha fetoprotein and epidermal growth factor conjugates in vitro and in vivo.
    Lutsenko SV; Feldman NB; Finakova GV; Gukasova NV; Petukhov SP; Posypanova GA; Skryabin KG; Severin SE
    Tumour Biol; 2000; 21(6):367-74. PubMed ID: 11006577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor efficiency of novel fluoro-substituted 6-amino-2-phenylbenzothiazole hydrochloride salts in vitro and in vivo.
    Stojkovic R; Karminski-Zamola G; Racane L; Tralic-Kulenovic V; Glavas-Obrovac L; Ivankovic S; Radacic M
    Methods Find Exp Clin Pharmacol; 2006; 28(6):347-54. PubMed ID: 16894403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-tumoural activity of peripheral blood mononuclear cells against melanoma cells: discrepant in-vitro and in-vivo effects.
    Joseph-Pietras D; Carlier A; Madoulet C; Albert P
    Melanoma Res; 2006 Aug; 16(4):325-33. PubMed ID: 16845328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lovastatin potentiates antitumor activity and attenuates cardiotoxicity of doxorubicin in three tumor models in mice.
    Feleszko W; Mlynarczuk I; Balkowiec-Iskra EZ; Czajka A; Switaj T; Stoklosa T; Giermasz A; Jakóbisiak M
    Clin Cancer Res; 2000 May; 6(5):2044-52. PubMed ID: 10815931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic activity, accumulation, and intracellular distribution of anthracycline antibiotics and their conjugates with the epidermal growth factor in sensitive and resistant MCF-7 cells.
    Lutsenko SV; Feldman NB; Gumanov SG; Rodina AV; Severin SE
    Biochemistry (Mosc); 2000 Nov; 65(11):1299-304. PubMed ID: 11112847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growth.
    Gil-Ad I; Shtaif B; Levkovitz Y; Nordenberg J; Taler M; Korov I; Weizman A
    Oncol Rep; 2006 Jan; 15(1):107-12. PubMed ID: 16328041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo cytotoxicity and antineoplastic activity of a transferrin-daunorubicin conjugate.
    Lemieux P; Pagé M; Noël C
    In Vivo; 1992; 6(6):621-7. PubMed ID: 1296812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo efficacy of acid-sensitive transferrin and albumin doxorubicin conjugates in a human xenograft panel and in the MDA-MB-435 mamma carcinoma model.
    Kratz F; Roth T; Fichiner I; Schumacher P; Fiebig HH; Unger C
    J Drug Target; 2000; 8(5):305-18. PubMed ID: 11328658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and preliminary antitumor activity evaluation of a DHA and doxorubicin conjugate.
    Wang Y; Li L; Jiang W; Yang Z; Zhang Z
    Bioorg Med Chem Lett; 2006 Jun; 16(11):2974-7. PubMed ID: 16563756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined use of chemotherapeutics and oncolytic adenovirus in treatment of AFP-expressing hepatocellular carcinoma.
    Mao CY; Hua HJ; Chen P; Yu DC; Cao J; Teng LS
    Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):282-7. PubMed ID: 19502169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the Raf signal transduction cascade in the in vitro resistance to the anticancer drug doxorubicin.
    Weinstein-Oppenheimer CR; Henríquez-Roldán CF; Davis JM; Navolanic PM; Saleh OA; Steelman LS; Franklin RA; Robinson PJ; McMahon M; McCubrey JA
    Clin Cancer Res; 2001 Sep; 7(9):2898-907. PubMed ID: 11555608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of doxorubicin-induced Fas expression in the antitumor effect of doxorubicin on Lewis lung carcinoma in vivo.
    Yoshimoto Y; Kawada M; Ikeda D; Ishizuka M
    Int Immunopharmacol; 2005 Feb; 5(2):281-8. PubMed ID: 15652759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.
    Traxler P; Allegrini PR; Brandt R; Brueggen J; Cozens R; Fabbro D; Grosios K; Lane HA; McSheehy P; Mestan J; Meyer T; Tang C; Wartmann M; Wood J; Caravatti G
    Cancer Res; 2004 Jul; 64(14):4931-41. PubMed ID: 15256466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-invasive and anti-metastatic effect of ampelopsin on melanoma].
    Zheng HQ; Liu DY
    Ai Zheng; 2003 Apr; 22(4):363-7. PubMed ID: 12703989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conjugates of mitomycin with anti-alpha-fetoprotein antibody: antitumor effect against alpha-fetoprotein-producing human gastric carcinoma implanted in nude mice.
    Takahashi Y; Mai M; Umemoto N; Kato Y; Hara T; Tsukada Y
    NCI Monogr; 1987; (3):101-5. PubMed ID: 2434869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase of therapeutic effects by treating melanoma with targeted combinations of c-myc antisense and doxorubicin.
    Pastorino F; Mumbengegwi DR; Ribatti D; Ponzoni M; Allen TM
    J Control Release; 2008 Feb; 126(1):85-94. PubMed ID: 18166243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 461.